A Single Dose Trial Investigating Safety and Local Tolerability of Ascending Doses of Long Acting Activated Recombinant Human Factor VII in Healthy Male Volunteers
This study has been completed.
Study NCT00951873
Information provided by Novo Nordisk
First Received on July 31, 2009.
Last Updated on July 4, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
